Biologics Overshadow Small Molecules In US FDA’s 2023 Novel Approvals

 
• By Bridget Silverman
  
teamwork
Biologics dominated the products entering the FDA's expedited approval programs in 2023. • Source: Shutterstock

More from Approvals

More from Product Reviews